|Incidences and Risk Factors of Organ Manifestations in the Early Course of Systemic Sclerosis: A Longitudinal EUSTAR Study|
VK Jaeger, EG Wirz, Y Allanore, P Rossbach, G Riemekasten, E Hachulla, ...
PloS one 11 (10), e0163894, 2016
|High colonization rates of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli in Swiss travellers to South Asia-a prospective observational multicentre cohort …|
E Kuenzli, VK Jaeger, R Frei, A Neumayr, S DeCrom, S Haller, J Blum, ...
BMC infectious diseases 14, 528-528, 2014
|Safety of live vaccinations on immunosuppressive therapy in patients with immune-mediated inflammatory diseases, solid organ transplantation or after bone-marrow …|
E Croce, C Hatz, EF Jonker, LG Visser, VK Jaeger, S Bühler
Vaccine 35 (9), 1216-1226, 2017
|The European Scleroderma Trials and Research group (EUSTAR) task force for the development of revised activity criteria for systemic sclerosis: derivation and validation of a …|
G Valentini, M Iudici, UA Walker, VK Jaeger, M Baron, P Carreira, ...
Annals of the Rheumatic Diseases 76 (1), 270-276, 2017
|Incidence and predictors of cutaneous manifestations during the early course of systemic sclerosis: a 10-year longitudinal study from the EUSTAR database|
EG Wirz, VK Jaeger, Y Allanore, G Riemekasten, E Hachulla, O Distler, ...
Annals of the rheumatic diseases, annrheumdis-2015-207271, 2015
|Functional disability and its predictors in systemic sclerosis: a study from the DeSScipher project within the EUSTAR group|
VK Jaeger, O Distler, B Maurer, L Czirják, V Lóránd, G Valentini, S Vettori, ...
Rheumatology, kex182, 2017
|Immune reconstitution after allogeneic hematopoietic stem cell transplantation and association with occurrence and outcome of invasive aspergillosis|
C Stuehler, E Kuenzli, VK Jaeger, V Baettig, F Ferracin, Z Rajacic, ...
The Journal of infectious diseases 212 (6), 959-967, 2015
|Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the European Scleroderma …|
W Wu, S Jordan, N Graf, J de Oliveira Pena, J Curram, Y Allanore, ...
Annals of the rheumatic diseases 78 (5), 648-656, 2019
|Safety of vaccinations in patients with cryopyrin-associated periodic syndromes: a prospective registry based study|
VK Jaeger, HM Hoffman, T van der Poll, H Tilson, J Seibert, A Speziale, ...
Rheumatology 56 (9), 1484-1491, 2017
|A profile of travelers—an analysis from a large Swiss travel clinic|
S Bühler, R Rüegg, R Steffen, C Hatz, VK Jaeger
Journal of travel medicine 21 (5), 324-331, 2014
|Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: a European Scleroderma Trials and Research (EUSTAR) analysis|
M Becker, N Graf, R Sauter, Y Allanore, J Curram, CP Denton, D Khanna, ...
Annals of the Rheumatic Diseases, annrheumdis-2019-215145, 2019
|The elderly, the young and the pregnant traveler--A retrospective data analysis from a large Swiss Travel Center with a special focus on malaria prophylaxis and yellow fever …|
VK Jaeger, N Tschudi, R Rüegg, C Hatz, S Bühler
Travel medicine and infectious disease 13 (6), 475-484, 2015
|Rituximab done: what’s next in rheumatoid arthritis? A European observational longitudinal study assessing the effectiveness of biologics after rituximab treatment in …|
UA Walker, VK Jaeger, K Chatzidionysiou, ML Hetland, EM Hauge, ...
Rheumatology 55 (2), 230-236, 2016
|Single-Dose Hepatitis A Immunization: 7.5-Year Observational Pilot Study in Nicaraguan Children to Assess Protective Effectiveness and Humoral Immune Memory Response|
O Mayorga, S Bühler, VK Jaeger, S Bally, C Hatz, G Frösner, U Protzer, ...
The Journal of infectious diseases 214 (10), 1498-1506, 2016
|Vasodilators and low-dose acetylsalicylic acid are associated with a lower incidence of distinct primary myocardial disease manifestations in systemic sclerosis: results of the …|
G Valentini, D Huscher, A Riccardi, S Fasano, R Irace, V Messiniti, ...
Annals of the Rheumatic Diseases 78 (11), 1576-1582, 2019
|Disease activity dynamics in rheumatoid arthritis: patients’ self-assessment of disease activity via WebApp|
UA Walker, RB Mueller, VK Jaeger, R Theiler, A Forster, P Dufner, F Ganz, ...
|Autopsy versus clinical findings in patients with systemic sclerosis in a case series from patients of the EUSTAR database|
B Sandmeier, VK Jäger, G Nagy, PE Carreira, A Tzankov, ...
Clin Exp Rheumatol 33 (4 Suppl 91), S75-9, 2015
|Use of vasoactive/vasodilating drugs for systemic sclerosis (SSc)-related digital ulcers (DUs) in expert tertiary centres: results from the analysis of the observational real …|
J Blagojevic, G Abignano, J Avouac, L Cometi, M Frerix, ...
Clinical rheumatology 39 (1), 27-36, 2020
|Racial differences in systemic sclerosis disease presentation: a European Scleroderma Trials and Research group study|
VK Jaeger, M Tikly, D Xu, E Siegert, E Hachulla, P Airò, G Valentini, ...
Rheumatology 59 (7), 1684-1694, 2020
|Peripheral neuropathy in antineutrophil cytoplasmic antibody-associated vasculitides: Insights from the DCVAS study|
A Bischof, VK Jaeger, RDM Hadden, RA Luqmani, AK Pröbstel, ...
Neurology-Neuroimmunology Neuroinflammation 6 (6), e615, 2019